Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis

被引：70
|
作者：
van Manen, Mirjam J. G. [1 ]
Birring, Surinder S. [2 ]
Vancheri, Carlo [3 ]
Vindigni, Virginia
Renzoni, Elisabetta [4 ]
Russell, Anne-Marie [4 ,5 ]
Wapenaar, Monique [1 ]
Cottin, Vincent [6 ]
Wijsenbeek, Marlies S. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Dept Resp Med, Rotterdam, Netherlands
[2] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England
[3] Univ Catania, Dept Clin & Expt Med, Sect Resp Dis, Catania, Italy
[4] Royal Brampton Hosp, Interstitial Lung Dis Unit, London, England
[5] Imperial Coll London, Natl Heart & Lung Inst, London, England
[6] Claude Bernard Lyon 1 Univ, Hosp Civils Lyon, Louis Pradel Hosp, Dept Resp Med, Lyon, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷 / 04期
基金：
美国国家卫生研究院;
关键词：
QUESTIONNAIRE; VALIDATION; DISEASE; REFLEX; TRIAL; LUNG;
D O I：
10.1183/13993003.01157-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Cough in Idiopathic Pulmonary Fibrosis
    Mann, Jennifer
    Goh, Nicole S. L.
    Holland, Anne E.
    Khor, Yet Hong
    FRONTIERS IN REHABILITATION SCIENCES, 2021, 2
  • [42] Analysis and review of patients with idiopathic pulmonary fibrosis treated with pirfenidone
    Valle Corpas, Margarita
    Casas Hidalgo, Inmaculada
    Rodriguez Delgado, Alejandro
    Moreno Raya, Patricia
    Moron Romero, Rocio
    Gonzalez Medina, Maria del Carmen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 333 - 334
  • [43] SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Flaherty, K. R.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    THORAX, 2017, 72 : A253 - A254
  • [44] A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    King, Talmadge E., Jr.
    Bradford, Williamson Z.
    Castro-Bernardini, Socorro
    Fagan, Elizabeth A.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Gorina, Eduard
    Hopkins, Peter M.
    Kardatzke, David
    Lancaster, Lisa
    Lederer, David J.
    Nathan, Steven D.
    Pereira, Carlos A.
    Sahn, Steven A.
    Sussman, Robert
    Swigris, Jeffrey J.
    Noble, Paul W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22): : 2083 - 2092
  • [45] Inspiration: An assistance program for idiopathic pulmonary fibrosis patients on pirfenidone
    MacQuarrie, Jessica
    Lebel, France
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [46] Outcomes in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Nolin, Maeva
    Dalon, Faustine
    Chia, Jenny
    Kirchgassler, Klaus
    Kamath, Tripthi
    Van Ganse, Eric
    Belhassen, Manon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 121 - 121
  • [47] Best tolerated dose of Pirfenidone in patients with idiopathic pulmonary fibrosis
    Agrawal, Neha
    Vaidya, Preyas J.
    Chavhan, Vinod B.
    Lele, Tejashree T.
    Leuppi-Taegtmeyer, Anne
    Leuppi, Joerg D.
    Chhajed, Prashant N.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [48] Pirfenidone in patients with advanced idiopathic pulmonary fibrosis: First experience
    Hoet, Filip
    Yzerbyt, Jonas
    Wuyts, Wim A.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [49] Cough Measurements In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Van Manen, M.
    Birring, S.
    Vancheri, C.
    Vindigni, V.
    Wapenaar, M.
    Cottin, V.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [50] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
12345